Showing results (111-120 of 777) with videos related to

Sort By:
Pageof 78
In Silico Pharmacology|September 22, 2025
In silico evaluation of berberine and silymarin against metabolic targets: a rationale for OMICS technology-based co-formulationAugustine Amalraj, V Anantha Narayanan, T S Ardra, et al.
In Silico Pharmacology|May 15, 2025
Zebrafish and bioactive compounds: a bibliometric reviewJoão Paulo Lima de Oliveira, Kiara Cândido Duarte da Silva, Bianca Aparecida de Sousa, et al.
In Silico Pharmacology|July 10, 2025
Exploring the therapeutic potential of Momordica charantia in targeting protein kinase C delta (PRKCD) for type 2 diabetes mellitus: insights from network pharmacology, molecular docking, and molecular dynamics simulationsRuchi Yadav, Nidhi Nambiar, Manushi Shah, et al.
In Silico Pharmacology|July 23, 2025
In silico identification of phytoconstituents from Capparis sepiaria as interleukin-1 inhibitors for rheumatoid arthritis: molecular docking, ADMET profiling, and molecular dynamics simulationDarius R Martin, Antoinette Ajmal, Mervin Meyer, et al.
In Silico Pharmacology|May 8, 2025
Chemoinformatics exploration of synthetically accessible N-heterocycles: uncovering new antifungal lead candidatesShiv Shankar Gupta, Veerbhan Kesarwani, Ravi Shankar, et al.
In Silico Pharmacology|May 2, 2025
Molecular Docking and anti-MRSA effects of bioactive compounds from CymbopogonM Vinutha, A Manikandan, R N Lakshmikanth, et al.
In Silico Pharmacology|October 27, 2025
Exploring nonstructural NS5B protein to design a multi-epitope-based vaccine against HCV: immuno-informatics approachNouman Ali, Adeeba Ali, Muhammad Sheraz Yousuf, et al.
In Silico Pharmacology|November 10, 2025
Tamarindus indica fruit pulp in neurodegeneration: a multimodal pharmacological studyLutfat A Usman, Emmanuel O Ajani, Afolabi C Akinmoladun, et al.
In Silico Pharmacology|October 20, 2025
Determining the efficacy of phytoconstituents of Ficus religiosa L. against dermatophytes through invitro and insilico approachesA Anitha, P Ponmurugan, V Hemamalini, et al.
In Silico Pharmacology|October 20, 2025
Overexpression of the TPX2 gene is associated with enhanced tumor malignancy in lung adenocarcinoma and identification of marine natural inhibitors of the Aurora kinase A-TPX2 protein complexMd Imtiaz, Partha Biswas, Md Mohaimenul Islam Tareq, et al.
Pageof 78